3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
22
Lymphoma
14
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Breast Neoplasms
11
Prostatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Multiple Myeloma
9
Melanoma
9
Lymphoma, Follicular
9
Neuroblastoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Ovarian Neoplasms
7
Congenital Abnormalities
7
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Lymphoma, Mantle-Cell
4
Leukemia, Myeloid, Chronic-Phase
4
Glioblastoma
4
Fallopian Tube Neoplasms
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Osteosarcoma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
Cytarabine
9
Etoposide
4
Daunorubicin
4
Idarubicin
3
Mitoxantrone
2
Gemtuzumab
2
Clofarabine
2
Asparaginase
2
tipifarnib
1
temsirolimus
1
palmitoyl-L-asparaginase
1
midostaurin
1
etoposide phosphate
1
eltrombopag
1
dexamethasone acetate
1
alvocidib
1
aldesleukin
1
Whole-Body Irradiation
1
Thioguanine
1
Proto-Oncogene Proteins c-kit
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Observation
1
Lenalidomide
1
Imatinib Mesylate
1
Gene Expression Profiling
1
Flow Cytometry
1
Filgrastim
1
Busulfan
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Eosinophilic, Acute
×
sargramostim
×
Clear all
No trials found.